Management Team

Janet Downie

Janet Downie

user Chief Executive Officer

Janet Downie is the CEO of RoslinCT. Janet has over 25 years of experience in biologics manufacturing and testing and was previously the COO for Roslin Cells Ltd and part of the original team that established the business. She then went on to set up the contract manufacturing division prior to the establishment of RoslinCT.

Janet has held various senior roles in operations and quality within Inveresk Research, PPL Therapeutics and Charles River Laboratories. She has always had a passion for business growth through delivering a quality service and a focus on patient safety. Janet holds a BSc (Hons) in Biological Sciences and is a member of UK Taskforce for ATMP Manufacturing and the BIA Cell Therapy and Manufacturing Committees.

Janet has a love for animals and has a house full of dogs and cats. She would have more if she could. She also enjoys spending time in the countryside and has recently developed a passion for fishing.

David McNab

David McNab

user Chief Financial Officer

David is responsible for all Finance related areas within the business and joined RoslinCT in 2017 to support the company’s strategic growth plans.

David has over 30 years of Financial and Commercial experience in a number of businesses within the Service Industries and was part of the team that grew and subsequently sold a global leading contract manufacturing and development organisation focused on liquid and semi-solid capsule products to a major US Pharmaceutical company.

David enjoys Golf and World Travel and spending time with his grandchildren.

Kevin Bruce

Kevin Bruce

user Chief Operating Officer

Kevin joined the team in 2019 as our Chief Operating Officer. He has more than 20 years working within a regulated scientific environment for small biotech, large CROs and SMEs.

With a background in quality control and engineering, Kevin has held positions in Operations, Quality, R&D and commercial development. He was previously responsible for Roslin Cells’ collaborative projects for the development, GMP translation and manufacture of cell therapies for both pre-clinical and clinical development. More recently, as COO at Censo Biotechnologies, he established the operational capability for the European Bank for Induced Pluripotent Stem Cells and was responsible for Censo’s stem cell generation, genome editing and assay development operations for drug discovery.

Kevin loves playing football and golf, hill walking and spending time with his family and friends!

Our Non-Executive Directors

Ian McCubbin

Ian McCubbin

user Chairman

Ian is a pharmacist with 30 years of experience in the Pharmaceutical industry working for GSK, Merck Generics and IVAX. His core capability is in the field of manufacturing and supply chain leadership. He was Chair of the Medicine Manufacturing Industry Partnership (MMIP) between 2013 and 2017 and chaired the Advanced Therapy Manufacturing Task Force to ‘anchor’ commercial-scale manufacturing in the UK. He has been a leading the manufacturing works stream of the UK Government Vaccines Task Force since May 2020 as an industry advisor.

David Bowie

David Bowie

user Board Member

David has over twenty-eight years of international sales, marketing management and business development experience in the global healthcare sector which led him to the board of the Scottish Government-backed Life Science Scotland Industry Leadership Group for some 12 years. David brings a wealth of life science industry experience, locally and globally, to the position.

Malcolm Bateman

Malcolm Bateman

user Board Member

CEO of the Roslin Foundation and a founder of Roslin Cells. Malcolm has extensive experience having held senior roles both in the UK and overseas with pharma and automotive multinationals. He has extensive board-level experience working in recent years with innovative SMEs and startups.

  • “RoslinCT is a fast-paced, vibrant company with employees from highly diverse backgrounds. The close-knit team is passionate and committed to delivering novel therapies for a variety of client processes.”

    Dr. Györgyi Talas, Quality Improvements Manager
  • “I joined RoslinCT at a really exciting time during the company’s growth, and it is so exciting to see all the vacancies we have planned for the next few years. The work we do is cutting edge and so inspiring and it is an honour to be involved in a company with such an impressive portfolio of services and such talented, driven and lovely staff.”

    Jessica McLachlan, Recruitment Officer
  • “I have been part of the RoslinCT team for a year and a half now and I have enjoyed every minute of it. RoslinCT instils a warm culture where there is mutual respect for one another and great opportunity for growth. I feel privileged to work in such a challenging and positive work environment where the focus is on delivering life-changing therapies for patients across the globe.”

    Katerina Tsita, Marketing Executive

Search